Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of estrogen receptor down-regulators for endocrine resistant breast cancer

The Journal of Steroid Biochemistry and Molecular Biology(2022)10.1016/j.jsbmb.2022.106162Source: DataRank Database

Identification of estrogen receptor down-regulators for endocrine resistant breast cancer is a research paper published in The Journal of Steroid Biochemistry and Molecular Biology (2022). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

6 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.01)OA: closedTopics (50)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Cody M. Orahoske ORCID,Shannon M. Urmetz,Wenjing Zhang ORCID,Yanmin Huang,Chunfang Gan ORCID

Live enrichment

PubMed:35932957 OpenAlex:https://openalex.org/W4289745912

National Natural Science Foundation of China

Grant: 21762008

NIH HHS

Grant: S10 OD025252

Cleveland State University

FWCI

1.01

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

closedLicense: https://doi.org/10.15223/policy-004

publisherhttps://api.elsevier.com/content/article/PII:S0960076022001133?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0960076022001133?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jsbmb.2022.106162

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35932957

Fields of Study

Estrogen and related hormone effectsAdvanced Breast Cancer TherapiesHER2/EGFR in Cancer ResearchHumansFemaleBreast NeoplasmsFulvestrantReceptors, EstrogenEstradiolAntineoplastic Agents, HormonalCell ProliferationCell Line, TumorEstrogensDrug Resistance, NeoplasmEstrogen Receptor alpha

MeSH Terms

FulvestrantBreast NeoplasmsEstradiolEstrogensFemaleHumansReceptors, EstrogenAntineoplastic Agents, HormonalDrug Resistance, NeoplasmCell Line, TumorEstrogen Receptor alphaCell Proliferation

Keywords

FulvestrantEstrogen receptorTamoxifenBreast cancerCancer researchEstrogen receptor alphaEstrogenMG132Downregulation and upregulationCancerEndocrine systemInternal medicineProteasome inhibitorChemistryEndocrinologyBiologyMedicineProteasomeHormoneBiochemistryEREndocrine ResistanceSteroidal Compounds

Sustainable Development Goals

SDG 0: Good health and well-being

Identification of estrogen receptor down-regulators for endocrine resistant breast cancer

FAIR Checklist

Authors (7)

Funding (3 grants)

Impact

Open Access

Topics